OTCMKTS:PFHO

Pacific Health Care Organization Competitors

$1.15
+0.01 (+0.88 %)
(As of 04/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.10
Now: $1.15
$1.15
50-Day Range
$1.00
MA: $1.12
$1.19
52-Week Range
$0.82
Now: $1.15
$1.30
Volume2,500 shs
Average Volume3,511 shs
Market Capitalization$14.72 million
P/E RatioN/A
Dividend YieldN/A
Beta0.5

Competitors

Pacific Health Care Organization (OTCMKTS:PFHO) Vs. FMS, DVA, SHC, PGNY, TVTY, and OTRK

Should you be buying PFHO stock or one of its competitors? Companies in the industry of "miscellaneous health & allied services, not elsewhere classified" are considered alternatives and competitors to Pacific Health Care Organization, including Fresenius Medical Care AG & Co. KGaA (FMS), DaVita (DVA), Sotera Health (SHC), Progyny (PGNY), Tivity Health (TVTY), and Ontrak (OTRK).

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Pacific Health Care Organization (OTCMKTS:PFHO) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability and dividends.

Profitability

This table compares Fresenius Medical Care AG & Co. KGaA and Pacific Health Care Organization's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Fresenius Medical Care AG & Co. KGaA7.38%10.62%4.15%
Pacific Health Care Organization10.25%6.86%6.12%

Institutional and Insider Ownership

1.6% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 61.6% of Pacific Health Care Organization shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Risk and Volatility

Fresenius Medical Care AG & Co. KGaA has a beta of 1.21, indicating that its stock price is 21% more volatile than the S&P 500. Comparatively, Pacific Health Care Organization has a beta of 0.5, indicating that its stock price is 50% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Fresenius Medical Care AG & Co. KGaA and Pacific Health Care Organization, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Fresenius Medical Care AG & Co. KGaA19702.35
Pacific Health Care Organization0000N/A

Fresenius Medical Care AG & Co. KGaA currently has a consensus target price of $45.00, suggesting a potential upside of 18.67%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, research analysts clearly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Pacific Health Care Organization.

Earnings and Valuation

This table compares Fresenius Medical Care AG & Co. KGaA and Pacific Health Care Organization's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA$19.58 billion1.13$1.34 billion$2.5314.99
Pacific Health Care Organization$7.33 million2.01$1.20 millionN/AN/A

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Pacific Health Care Organization.

Summary

Fresenius Medical Care AG & Co. KGaA beats Pacific Health Care Organization on 7 of the 11 factors compared between the two stocks.

Pacific Health Care Organization (OTCMKTS:PFHO) and DaVita (NYSE:DVA) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

Profitability

This table compares Pacific Health Care Organization and DaVita's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Pacific Health Care Organization10.25%6.86%6.12%
DaVita7.32%43.99%5.27%

Insider & Institutional Ownership

91.7% of DaVita shares are owned by institutional investors. 61.6% of Pacific Health Care Organization shares are owned by company insiders. Comparatively, 1.0% of DaVita shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Volatility & Risk

Pacific Health Care Organization has a beta of 0.5, meaning that its share price is 50% less volatile than the S&P 500. Comparatively, DaVita has a beta of 1.3, meaning that its share price is 30% more volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and recommmendations for Pacific Health Care Organization and DaVita, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Pacific Health Care Organization0000N/A
DaVita13102.00

DaVita has a consensus price target of $114.60, suggesting a potential upside of 4.32%. Given DaVita's higher probable upside, analysts clearly believe DaVita is more favorable than Pacific Health Care Organization.

Valuation & Earnings

This table compares Pacific Health Care Organization and DaVita's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pacific Health Care Organization$7.33 million2.01$1.20 millionN/AN/A
DaVita$11.39 billion1.06$810.98 million$5.4020.34

DaVita has higher revenue and earnings than Pacific Health Care Organization.

Summary

DaVita beats Pacific Health Care Organization on 7 of the 11 factors compared between the two stocks.

Pacific Health Care Organization (OTCMKTS:PFHO) and Sotera Health (NYSE:SHC) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

Profitability

This table compares Pacific Health Care Organization and Sotera Health's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Pacific Health Care Organization10.25%6.86%6.12%
Sotera HealthN/AN/AN/A

Analyst Ratings

This is a summary of current ratings and recommmendations for Pacific Health Care Organization and Sotera Health, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Pacific Health Care Organization0000N/A
Sotera Health001003.00

Sotera Health has a consensus price target of $32.75, suggesting a potential upside of 26.89%. Given Sotera Health's higher probable upside, analysts clearly believe Sotera Health is more favorable than Pacific Health Care Organization.

Valuation & Earnings

This table compares Pacific Health Care Organization and Sotera Health's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pacific Health Care Organization$7.33 million2.01$1.20 millionN/AN/A
Sotera HealthN/AN/AN/AN/AN/A

Pacific Health Care Organization has higher revenue and earnings than Sotera Health.

Summary

Pacific Health Care Organization beats Sotera Health on 4 of the 6 factors compared between the two stocks.

Pacific Health Care Organization (OTCMKTS:PFHO) and Progyny (NASDAQ:PGNY) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, earnings, profitability and dividends.

Analyst Ratings

This is a summary of recent recommendations for Pacific Health Care Organization and Progyny, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Pacific Health Care Organization0000N/A
Progyny00603.00

Progyny has a consensus price target of $38.8333, indicating a potential downside of 22.83%. Given Progyny's higher probable upside, analysts clearly believe Progyny is more favorable than Pacific Health Care Organization.

Insider & Institutional Ownership

58.5% of Progyny shares are held by institutional investors. 61.6% of Pacific Health Care Organization shares are held by insiders. Comparatively, 33.3% of Progyny shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares Pacific Health Care Organization and Progyny's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pacific Health Care Organization$7.33 million2.01$1.20 millionN/AN/A
Progyny$229.68 million19.11$-8,570,000.00$0.11457.45

Pacific Health Care Organization has higher earnings, but lower revenue than Progyny.

Volatility & Risk

Pacific Health Care Organization has a beta of 0.5, suggesting that its share price is 50% less volatile than the S&P 500. Comparatively, Progyny has a beta of 1.83, suggesting that its share price is 83% more volatile than the S&P 500.

Profitability

This table compares Pacific Health Care Organization and Progyny's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Pacific Health Care Organization10.25%6.86%6.12%
Progyny1.03%7.43%5.04%

Summary

Progyny beats Pacific Health Care Organization on 7 of the 11 factors compared between the two stocks.

Tivity Health (NASDAQ:TVTY) and Pacific Health Care Organization (OTCMKTS:PFHO) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations and dividends.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Tivity Health and Pacific Health Care Organization, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Tivity Health12502.50
Pacific Health Care Organization0000N/A

Tivity Health presently has a consensus price target of $22.1250, indicating a potential downside of 6.21%. Given Tivity Health's higher possible upside, research analysts clearly believe Tivity Health is more favorable than Pacific Health Care Organization.

Insider & Institutional Ownership

91.6% of Tivity Health shares are held by institutional investors. 11.8% of Tivity Health shares are held by company insiders. Comparatively, 61.6% of Pacific Health Care Organization shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Valuation and Earnings

This table compares Tivity Health and Pacific Health Care Organization's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tivity Health$1.13 billion1.03$-286,820,000.00$2.0211.68
Pacific Health Care Organization$7.33 million2.01$1.20 millionN/AN/A

Pacific Health Care Organization has lower revenue, but higher earnings than Tivity Health.

Risk & Volatility

Tivity Health has a beta of 2.49, meaning that its stock price is 149% more volatile than the S&P 500. Comparatively, Pacific Health Care Organization has a beta of 0.5, meaning that its stock price is 50% less volatile than the S&P 500.

Profitability

This table compares Tivity Health and Pacific Health Care Organization's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Tivity Health-47.44%128.43%6.11%
Pacific Health Care Organization10.25%6.86%6.12%

Summary

Tivity Health beats Pacific Health Care Organization on 6 of the 11 factors compared between the two stocks.

Ontrak (NASDAQ:OTRK) and Pacific Health Care Organization (OTCMKTS:PFHO) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations and dividends.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Ontrak and Pacific Health Care Organization, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ontrak02302.60
Pacific Health Care Organization0000N/A

Ontrak presently has a consensus price target of $47.20, indicating a potential upside of 50.70%. Given Ontrak's higher possible upside, research analysts clearly believe Ontrak is more favorable than Pacific Health Care Organization.

Insider & Institutional Ownership

27.5% of Ontrak shares are held by institutional investors. 58.2% of Ontrak shares are held by company insiders. Comparatively, 61.6% of Pacific Health Care Organization shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Valuation and Earnings

This table compares Ontrak and Pacific Health Care Organization's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ontrak$35.10 million15.78$-25,660,000.00($1.15)-27.23
Pacific Health Care Organization$7.33 million2.01$1.20 millionN/AN/A

Pacific Health Care Organization has lower revenue, but higher earnings than Ontrak.

Risk & Volatility

Ontrak has a beta of 2.52, meaning that its stock price is 152% more volatile than the S&P 500. Comparatively, Pacific Health Care Organization has a beta of 0.5, meaning that its stock price is 50% less volatile than the S&P 500.

Profitability

This table compares Ontrak and Pacific Health Care Organization's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ontrak-43.10%N/A-58.54%
Pacific Health Care Organization10.25%6.86%6.12%

Summary

Ontrak beats Pacific Health Care Organization on 6 of the 11 factors compared between the two stocks.


Pacific Health Care Organization Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Fresenius Medical Care AG & Co. KGaA logo
FMS
Fresenius Medical Care AG & Co. KGaA
1.7$37.92+0.6%$22.21 billion$19.58 billion15.05
DaVita logo
DVA
DaVita
1.7$109.85+1.5%$12.02 billion$11.39 billion16.47
Sotera Health logo
SHC
Sotera Health
2.0$25.81+0.5%$7.30 billionN/A0.00Analyst Upgrade
Progyny logo
PGNY
Progyny
1.5$50.32+0.9%$4.39 billion$229.68 million457.45
Tivity Health logo
TVTY
Tivity Health
1.0$23.59+0.9%$1.16 billion$1.13 billion-2.13News Coverage
Ontrak logo
OTRK
Ontrak
1.7$31.32+0.1%$554.05 million$35.10 million-18.42
SOC Telemed logo
TLMD
SOC Telemed
1.6$6.95+2.3%$533.57 millionN/A0.00Unusual Options Activity
Viemed Healthcare logo
VMD
Viemed Healthcare
1.1$9.79+0.4%$383.62 million$80.26 million13.60
HemaCare logo
HEMA
HemaCare
0.5$25.31+0.6%$346.52 millionN/A0.00
Caladrius Biosciences logo
CLBS
Caladrius Biosciences
1.5$1.55+3.9%$92.22 millionN/A-2.42Decrease in Short Interest
Baudax Bio logo
BXRX
Baudax Bio
1.4$1.06+6.6%$74.35 millionN/A-0.30Analyst Upgrade
Increase in Short Interest
Gap Down
Cryo-Cell International logo
CCEL
Cryo-Cell International
0.9$9.67+0.8%$73.82 million$31.80 million24.18High Trading Volume
Gap Down
GRNV
GreenVision Acquisition
0.3$10.17+0.1%$73.10 millionN/A0.00Increase in Short Interest
Emmaus Life Sciences logo
EMMA
Emmaus Life Sciences
0.2$1.30+3.8%$63.68 million$1.32 million0.00News Coverage
Gap Up
CTYX
Curative Biotechnology
0.0$0.15+3.4%$61.66 millionN/A0.00Decrease in Short Interest
Gap Up
PFHOD
Pacific Health Care Organization
0.5$1.25+228.0%$52.48 million$6.80 million0.00Gap Up
BRTXQ
BioRestorative Therapies
0.0$0.01+0.0%$17.05 million$110,000.00-0.01Gap Down
BioRestorative Therapies logo
BRTX
BioRestorative Therapies
0.6$0.01+0.0%$17.05 million$110,000.000.00Decrease in Short Interest
Gap Down
GNOW
American Caresource
0.7$0.01+165.3%$199,000.00N/A0.00Gap Up
HYBE
Hybrid Energy
0.0$0.00+0.0%$0.00N/A0.00Increase in Short Interest
News Coverage
QMED
QMed
0.2$0.00+0.0%$0.00N/A0.00
This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.